Swiss National Bank
ALT icon

Swiss National Bank’s Altimmune ALT Stock Holding History

Swiss National Bank’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-139,500
Closed -$698K – 2335
2025
Q1 		$698K Hold
139,500
– – ﹤0.01% 2273
2024
Q4 		$1.01M Hold
139,500
– – ﹤0.01% 2204
2024
Q3 		$857K Hold
139,500
– – ﹤0.01% 2281
2024
Q2 		$928K Buy
139,500
+33,500
+32% +$247K ﹤0.01% 2203
2024
Q1 		$1.08M Buy
+106,000
New +$1.08M ﹤0.01% 2183
2023
Q2 		– Sell
-106,100
Closed -$448K – 2605
2023
Q1 		$448K Sell
106,100
-12,200
-10% -$145K ﹤0.01% 2548
2022
Q4 		$1.95M Buy
+118,300
New +$1.33M ﹤0.01% 1913

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Swiss National Bank's ALT Position: Q2 2025 in Review

Swiss National Bank sold out of Altimmune (ALT) in Q2 2025, closing a stake of 139,500 shares — an estimated $698K sold.

Swiss National Bank first reported a position in ALT in Q4 2022 and held it in 7 quarters. The position peaked at $1.95M in Q4 2022. 180 funds tracked by Wall St. Rank hold ALT as of Q2 2025.

  • Swiss National Bank reported no remaining Altimmune position as of Q2 2025 after selling out during the quarter.
  • Swiss National Bank sold 139,500 Altimmune shares in Q2 2025, an estimated $698K.
  • Swiss National Bank first reported a position in Altimmune in Q4 2022 and held it in 7 quarters.
  • Swiss National Bank's Altimmune position peaked at $1.95M in Q4 2022.
  • 180 funds tracked by Wall St. Rank held Altimmune as of Q2 2025.

Based on Swiss National Bank's 13F filing for Q2 2025, filed 12 Aug 2025.